Clinical utility of targeted SARS-CoV-2 serology testing to aid the diagnosis and management of suspected missed, late or post-COVID-19 infection syndromes: Results from a pilot service implemented during the first pandemic wave.
Sweeney N, Merrick B, Pedro Galão R, Pickering S, Botgros A, Wilson HD, Signell AW, Betancor G, Tan MKI, Ramble J, Kouphou N, Acors S, Graham C, Seow J, MacMahon E, Neil SJD, Malim MH, Doores K, Douthwaite S, Batra R, Nebbia G, Edgeworth JD.
Sweeney N, et al. Among authors: batra r.
PLoS One. 2021 Apr 7;16(4):e0249791. doi: 10.1371/journal.pone.0249791. eCollection 2021.
PLoS One. 2021.
PMID: 33826651
Free PMC article.
Clinical Trial.